Literature DB >> 22990373

Energy metabolism in cardiac remodeling and heart failure.

Paula S Azevedo1, Marcos F Minicucci, Priscila P Santos, Sergio A R Paiva, Leonardo A M Zornoff.   

Abstract

Fatty acids are the main substrates used by mitochondria to provide myocardial energy under normal conditions. During heart remodeling, however, the fuel preference switches to glucose. In the earlier stages of cardiac remodeling, changes in energy metabolism are considered crucial to protect the heart from irreversible damage. Furthermore, low fatty acid oxidation and the stimulus for glycolytic pathway lead to lipotoxicity, acidosis, and low adenosine triphosphate production. While myocardial function is directly associated with energy metabolism, the metabolic pathways could be potential targets for therapy in heart failure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22990373     DOI: 10.1097/CRD.0b013e318274956d

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  29 in total

Review 1.  Epigenetics of the failing heart.

Authors:  José Marín-García; Alexander T Akhmedov
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

Review 2.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 3.  The Modulating Effects of Cardiac Resynchronization Therapy on Myocardial Metabolism in Heart Failure.

Authors:  Yi-Zhou Xu; Chao-Feng Chen; Bin Chen; Xiao-Fei Gao; Wei Hua; Yong-Mei Cha; Petras P Dzeja
Journal:  Pacing Clin Electrophysiol       Date:  2016-12-07       Impact factor: 1.976

Review 4.  Adrenergic signaling in heart failure and cardiovascular aging.

Authors:  Gaetano Santulli; Guido Iaccarino
Journal:  Maturitas       Date:  2016-03-26       Impact factor: 4.342

Review 5.  Metabolic remodeling in chronic heart failure.

Authors:  Jing Wang; Tao Guo
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

6.  Proteomics reveals Rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice.

Authors:  Sarah J Parker; Aleksandr Stotland; Elena MacFarlane; Nicole Wilson; Amanda Orosco; Vidya Venkatraman; Kyle Madrid; Roberta Gottlieb; Harry C Dietz; Jennifer E Van Eyk
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-13       Impact factor: 4.733

Review 7.  Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.

Authors:  Alexander T Akhmedov; Vitalyi Rybin; José Marín-García
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

8.  Abnormal left ventricular global strain during exercise-test in young healthy smokers.

Authors:  Giuseppe Mandraffino; Egidio Imbalzano; Alberto Lo Gullo; Concetta Zito; Carmela Morace; Maria Cinquegrani; Francesca Savarino; Lilia Oreto; Clemente Giuffrida; Scipione Carerj; Giovanni Squadrito
Journal:  Sci Rep       Date:  2020-03-30       Impact factor: 4.379

Review 9.  Mesenchymal stem cell-derived extracellular vesicles in the failing heart: past, present, and future.

Authors:  Catherine Karbasiafshar; Frank W Sellke; M Ruhul Abid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-16       Impact factor: 4.733

10.  The role of lipotoxicity in smoke cardiomyopathy.

Authors:  Priscila P Santos; Fernando Oliveira; Vanessa C M P Ferreira; Bertha F Polegato; Meliza G Roscani; Ana Angelica Fernandes; Pamela Modesto; Bruna P M Rafacho; Silmeia G Zanati; Annarita Di Lorenzo; Luiz S Matsubara; Sergio A R Paiva; Leonardo A M Zornoff; Marcos F Minicucci; Paula S Azevedo
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.